Coloplast A/S (LTS:0QBO) Net Income From Continuing Operations : kr6,938 Mil (TTM As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Coloplast A/S Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Coloplast A/S's net income from continuing operations for the three months ended in Mar. 2024 was kr1,772 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was kr6,938 Mil.

Coloplast A/S Net Income From Continuing Operations Historical Data

The historical data trend for Coloplast A/S's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Net Income From Continuing Operations Chart

Coloplast A/S Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Net Income From Continuing Operations

Get a 7-Day Free Trial

5,156.00

5,854.00

6,155.00

6,439.00

6,771.00

Coloplast A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															1,651.00	1,714.00	1,645.00	1,807.00	1,772.00

Coloplast A/S Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr6,938 Mil.

Coloplast A/S (LTS:0QBO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (LTS:0QBO) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

CLPBY:USA CLPBF:USA COLOBc:UK COLO B:Denmark CBHD:Germany

Address

Holtedam 1-3, Humlebaek, DNK, DK-3050

Website

https://www.coloplast.com

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (LTS:0QBO) Headlines

No Headlines